Cargando…

Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects

Fibroblast growth factor (FGF) 21 is a class of hepatokines that plays a protective role against obesity, insulin resistance, and liver damage. Despite this, protective effects of FGF21 in human appear to be minimal, possibly due to its proteolytic cleavage by the fibroblast activation protein (FAP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Jae Min, Yang, Eun Hee, Quan, Wenying, Nam, Eun Hye, Cheon, Hyae Gyeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718273/ https://www.ncbi.nlm.nih.gov/pubmed/33277568 http://dx.doi.org/10.1038/s41598-020-77978-z

Ejemplares similares

Activating transcription factor-3 induction is involved in the anti-inflammatory action of berberine in RAW264.7 murine macrophages
por: Bae, Young-An, et al.
Publicado: (2016)

The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

5-LO inhibition ameliorates palmitic acid-induced ER stress, oxidative stress and insulin resistance via AMPK activation in murine myotubes
por: Kwak, Hyun Jeong, et al.
Publicado: (2017)

APC(+/−) alters colonic fibroblast proteome in FAP
por: Patel, Bhavinkumar B., et al.
Publicado: (2011)

Radioligands Targeting Fibroblast Activation Protein (FAP)
por: Lindner, Thomas, et al.
Publicado: (2021)

The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017)

Anti-obesity effects of Lactiplantibacillus plantarum SKO-001 in high-fat diet-induced obese mice
por: Choi, Mi Jin, et al.
Publicado: (2023)

KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
por: Velázquez, Ana Magdalena, et al.
Publicado: (2022)

Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization
por: Jeon, Eun Jeong, et al.
Publicado: (2019)

Author Correction: Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization
por: Jeon, Eun Jeong, et al.
Publicado: (2020)

Design, Synthesis and Preclinical Assessment of (99m)Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
por: Trujillo-Benítez, Diana, et al.
Publicado: (2022)

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA
por: Backhaus, P., et al.
Publicado: (2021)

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
por: Paka, Latha, et al.
Publicado: (2017)

Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of palmitic acid into triglycerides in C2C12
por: Cheon, Hyae Gyeong, et al.
Publicado: (2014)

Fibroblast activation protein (FAP) as a novel metabolic target
por: Sánchez-Garrido, Miguel Angel, et al.
Publicado: (2016)

Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy
por: Huang, Ting, et al.
Publicado: (2015)

Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion
por: Jiménez-Castro, Mónica B., et al.
Publicado: (2019)

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts
por: Da, Ben L, et al.
Publicado: (2022)

Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP)
por: Bainbridge, Travis W., et al.
Publicado: (2017)

Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
por: Lin, Yuli, et al.
Publicado: (2019)

Radiation-induced FAP + fibroblasts are involved in keloid recurrence after radiotherapy
por: Gao, Yan, et al.
Publicado: (2022)

Triglyceride Mobilization from Lipid Droplets Sustains the Anti-Steatotic Action of Iodothyronines in Cultured Rat Hepatocytes
por: Grasselli, Elena, et al.
Publicado: (2016)

Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients
por: Šeda, Ondrej, et al.
Publicado: (2019)

The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
por: Micó-Carnero, Marc, et al.
Publicado: (2022)

The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD(2) Antibody Dinutuximab Beta
por: Siebert, Nikolai, et al.
Publicado: (2022)

The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?
por: Sane, Rajas, et al.
Publicado: (2022)

First Evidence of Anti-Steatotic Action of Macrotympanain A1, an Amphibian Skin Peptide from Odorrana macrotympana
por: Demori, Ilaria, et al.
Publicado: (2022)

Anti-Steatotic Effects of Chlorella vulgaris, Nannochloropsis gaditana and Gracilaria vermiculophylla Algae Extracts in AML-12 Hepatocytes
por: González-Arceo, Maitane, et al.
Publicado: (2023)

Suppression of Adipocyte Differentiation by Foenumoside B from Lysimachia foenum-graecum Is Mediated by PPARγ Antagonism
por: Kwak, Hyun Jeong, et al.
Publicado: (2016)

Involvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast Differentiation
por: Kang, Ju-Hee, et al.
Publicado: (2015)

The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK/mTOR/lipogenesis Pathways
por: Oriquat, Ghaleb, et al.
Publicado: (2023)

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion
por: Mosbah, I Ben, et al.
Publicado: (2010)

Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers
por: Haq, Adeel, et al.
Publicado: (2023)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer
por: Herrera, Mercedes, et al.
Publicado: (2020)

Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours
por: Solano-Iturri, Jon Danel, et al.
Publicado: (2020)

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
por: Bughda, Reyisa, et al.
Publicado: (2021)

Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
por: Roustaei, Hessamoddin, et al.
Publicado: (2022)

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
por: Zboralski, Dirk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ifbqu3ufjeg8thd81s6keqm628